These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21959281)

  • 1. Ezogabine (retigabine).
    Stafstrom CE; Grippon S; Kirkpatrick P
    Nat Rev Drug Discov; 2011 Sep; 10(10):729-30. PubMed ID: 21959281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retigabine for partial onset seizures.
    Rheims S; Ryvlin P
    Expert Rev Neurother; 2012 May; 12(5):509-17. PubMed ID: 22550979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezogabine: development and role in the management of epileptic seizures.
    Verma A; Kumar R; Kumar M
    Mini Rev Med Chem; 2013 Apr; 13(5):697-705. PubMed ID: 22931529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezogabine (retigabine) and its role in the treatment of partial-onset seizures: a review.
    Splinter MY
    Clin Ther; 2012 Sep; 34(9):1845-56.e1. PubMed ID: 22917854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
    Tompson DJ; Crean CS; Reeve R; Berry NS
    Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACS chemical neuroscience molecule spotlight on Potiga (Ezogabine).
    Hopkins CR
    ACS Chem Neurosci; 2012 Aug; 3(8):632. PubMed ID: 22896808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of retigabine/ezogabine.
    Tompson DJ; Crean CS
    Curr Clin Pharmacol; 2013 Nov; 8(4):319-31. PubMed ID: 23342983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retigabine. A novel anticonvulsant drug for the adjunctive treatment of partial seizures].
    Hecht B
    Med Monatsschr Pharm; 2012 May; 35(5):166-71. PubMed ID: 22624350
    [No Abstract]   [Full Text] [Related]  

  • 9. Ezogabine (Potiga) for epilepsy.
    Med Lett Drugs Ther; 2012 Aug; 54(1397):65-7. PubMed ID: 22907178
    [No Abstract]   [Full Text] [Related]  

  • 10. Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults.
    Yamada M; Welty TE
    Ann Pharmacother; 2012 Oct; 46(10):1358-67. PubMed ID: 22991134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
    Lim KS; Lotay N; White R; Kwan P
    Epilepsy Behav; 2016 Aug; 61():224-230. PubMed ID: 27376872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezogabine (Potiga) toxicity.
    Med Lett Drugs Ther; 2013 Nov; 55(1430):96. PubMed ID: 24276503
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.
    Nass RD; Kurth C; Kull A; Graf W; Kasper B; Hamer HM; Strzelczyk A; Elger CE; Steinhoff BJ; Surges R; Rosenow F
    Epilepsy Behav; 2016 Mar; 56():54-8. PubMed ID: 26828693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comment on Craig et al.: ''Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization: a NICE single technology appraisal''.
    Holko P; Kawalec P
    Pharmacoeconomics; 2013 Jun; 31(6):533-5. PubMed ID: 23539279
    [No Abstract]   [Full Text] [Related]  

  • 15. Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal.
    Craig D; Rice S; Paton F; Fox D; Woolacott N
    Pharmacoeconomics; 2013 Feb; 31(2):101-10. PubMed ID: 23341194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset seizures.
    Owen RT
    Drugs Today (Barc); 2010 Nov; 46(11):815-22. PubMed ID: 21225020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
    Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
    Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.
    Rudzinski LA; Vélez-Ruiz NJ; Gedzelman ER; Mauricio EA; Shih JJ; Karakis I
    J Investig Med; 2016 Aug; 64(6):1087-101. PubMed ID: 27252470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
    French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
    Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retigabine: in partial seizures.
    Plosker GL; Scott LJ
    CNS Drugs; 2006; 20(7):601-8; discussion 609-10. PubMed ID: 16800718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.